Currently Viewing:
Newsroom
Currently Reading
Survey Identifies Americans' Preferences for Pain Management
November 20, 2017 – Jaime Rosenberg
How the Gut Microbiome Is Affecting Immunotherapy Response
November 20, 2017 – Laura Joszt
What We're Reading: Mandate Repeal Uncertainty; Destroying Antitrust Evidence; PTSD After Cancer
November 20, 2017 – AJMC Staff
This Week in Managed Care: November 17, 2017
November 17, 2017
Study Supports Use of Intravenous Golimumab in Treating Psoriatic Arthritis
November 17, 2017 – Kelly Davio
ASCO's TAPUR Study Expands to Enroll Patients Receiving Immunotherapy
November 17, 2017 – AJMC Staff
AJMC® in the Press, November 17, 2017
November 17, 2017 – AJMC Staff
What We're Reading: Gene Therapy Guidelines; Opioid Overdose Costs; Unaware of Open Enrollment
November 17, 2017 – AJMC Staff
5 Things About the New Hypertension Guidelines
November 17, 2017 – Mary Caffrey

More Evidence Not All Prostate Cancers Need Treatment

In a study of older men who had died from causes other than prostate cancer, almost half were found to have prostate tumors. And up to half of those tumors detected on autopsy would have qualified for treatment had doctors known about them while the men lived, though none had been the cause of death.
In a study of older men who had died from causes other than prostate cancer, almost half were found to have prostate tumors.

And up to half of those tumors detected on autopsy would have qualified for treatment had doctors known about them while the men lived, though none had been the cause of death.

That suggests the criteria for treatment "might be worth reexamining," according to the study authors, and adds to a growing body of evidence that a wait-and-see approach might be better than treatment for many prostate cancers.

"The study suggests that the progression of early prostate cancer, including some more aggressive forms of the disease, is far from inevitable within a man's lifetime as many such tumors are found in men who died from other causes when their prostate is analyzed on autopsy," said lead author Dr. Alexandre Zlotta, director of Uro-oncology at Mount Sinai Hospital in New York.

Read the full story here: http://reut.rs/12Y9cnE

Source: Reuters


 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!